ASCO-pp/ Views and analysis Eye on ASCO Day 3 – Pricey combos cause panic Kevin Grogan asco, cancer, Haematology, pricing, respiratory 0 Comment But is it pharma’s fault? Share X Eye on ASCO Day 3 – Pricey combos cause panic https://pharmaphorum.com/views-and-analysis/eye-on-asco-day-2-pricey-combos-cause-panic/
ASCO-pp/ Clinical/ Views and analysis Eye on ASCO Day 2 – Precision medicine takes centre stage Kevin Grogan asco, Bristol-Myers Squibb, cancer, Oncology, precision medicine, Roche 0 Comment Data from one of the largest cancer genomics studies ever conducted. Share X Eye on ASCO Day 2 – Precision medicine takes centre stage https://pharmaphorum.com/views-and-analysis/eye-on-asco-day-2-precision-medicine-takes-centre-stage/
ASCO-pp/ Healthcare/ Views and analysis Eye on ASCO Day 1 – There’s life in the old drugs yet Kevin Grogan asco, biosimilar, cancer, herceptin, Oncology, pharma, Roche 0 Comment The American Society of Clinical Oncology meeting, the world’s biggest cancer conference, has kicked off in blazing sunshine Share X Eye on ASCO Day 1 – There’s life in the old drugs yet https://pharmaphorum.com/views-and-analysis/eye-on-asco-day-1-theres-life-in-the-old-drugs-yet/